“Targeted Immunotherapy With a Checkpoint Inhibitor in Combination With Chemotherapy: A New Clinical Paradigm in the Treatment of Triple-Negative Breast Cancer”. 2019. Biomolecules and Biomedicine 19 (3): 227-33. https://doi.org/10.17305/bjbms.2019.4204.